Abstract:Systemic amyloidoses, an important class of protein misfolding diseases, are often due to fibrillation of disulfide-cross-linked globular proteins otherwise unrelated in sequence or structure. Although cross-beta assembly is regarded as a universal property of polypeptides, it is not understood how such amyloids accommodate diverse disulfide connectivities. Does amyloidogenicity depend on protein topology? A model is provided by insulin, a two-chain protein containing three disulfide bridges. The importance of chain topology is demonstrated by mini-proinsulin (MP), a single-chain analogue in which the C-terminus of the B chain (residue B30) is tethered to the N-terminus of the A chain (A1). The B30-A1 tether impedes the fiber-specific alpha -> beta transition, leading to slow formation of a structurally nonuniform amorphous precipitate. Conversely, fibrillation is robust to interchange of disulfide bridges. Whereas native insulin exhibits pairings [A6-A11, A7-B7, and A20-B19], metastable isomers with alternative pairings [A6-B7, A7-A11, A20-B19] or [A6-A7, A11-B7, A20-B1] readily undergo fibrillation with essentially identical alpha -> beta, transitions. Respective pairing schemes are in each case retained. Isomeric fibrils and the amorphous MP precipitate are each able to seed the fibrillation of wild-type insulin, suggesting a structural correspondence between respective nuclei or modes of assembly. Together, our results demonstrate that effects of polypeptide topology on amyloidogenicity depend on structural context. Although the native structures and stabilities of single-chain insulin analogues are similar to those of wild-type insulin, the interchain tether constrains the extent of conformational distortion at elevated temperature, retards initial non-native aggregation, and is apparently incompatible with the mature structure of an insulin protofilament. We speculate that the general danger of fibrillation has imposed a constraint in protein evolution, selecting for topologies unfavorable to amyloid formation.

Lability landscape and protease resistance of human insulin amyloid: a new insight into its molecular properties

Study of Insulin Aggregation and Fibril Structure under Different Environmental Conditions

Monitoring and Inhibition of Insulin Fibrillation by a Small Organic Fluorogen with Aggregation-Induced Emission Characteristics.

Clues to the Design of Aggregation-Resistant Insulin from Proline Scanning of Highly Amyloidogenic Peptides Derived from the N-Terminal Segment of the A-Chain

Insulin glycation by methylglyoxal results in native-like aggregation and inhibition of fibril formation

Early Events in Insulin Fibrillization Studied by Time-Lapse Atomic Force Microscopy

Residual Structure in Islet Amyloid Polypeptide Mediates Its Interactions with Soluble Insulin.

An Achilles' Heel in an Amyloidogenic Protein and Its Repair: INSULIN FIBRILLATION AND THERAPEUTIC DESIGN

Atomic resolution structure of full-length human insulin fibrils

Insulin Amyloid Fibrillation Studied by Terahertz Spectroscopy and Other Biophysical Methods

Beyond amino acid sequence: disulfide bonds and the origins of the extreme amyloidogenic properties of insulin's H‐fragment

Elucidating the Degradation Pathways of Human Insulin in the Solid State

Amyloid Morphology is Encoded in H-bonds and Electrostatics Interactions Ruling Protein Phase Separation

Dissecting the role of disulfide bonds on the amyloid formation of insulin.

Anion–Induced Amyloid Fibrillation of Human Insulin In vitro

Structure and Thermodynamics of Amylin Dimer Studied by Hamiltonian-Temperature Replica Exchange Molecular Dynamics Simulations

Structure-Specific Effects of Protein Topology on Cross-Beta Assembly: Studies of Insulin Fibrillation

Ph-Dependent Interactions Of Human Islet Amyloid Polypeptide Segments With Insulin Studied By Replica Exchange Molecular Dynamics Simulations

Short Peptide Segment and Insulin Co-Assembly Forms Cytotoxic Oligomers

Influence of Hydrophobicity on the Surface-Catalyzed Assembly of the Islet Amyloid Polypeptide

pH-induced molecular shedding drives the formation of amyloid fibril-derived oligomers